FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to the improved thrombopoietin TPO) mimetic representing 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-yliden]hydrazine]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine). Also, invention relates to a pharmaceutical composition based on indicated salt of the compound, method for treatment of thrombocytopenia in mammal, method for enhancing platelets producing in mammal and methods for preparing indicated pharmaceutical composition and indicated salt of the compound. Invention provides the enhanced solubility of proposed salt as compared with free acid that results to alleviation in preparing the pharmaceutical composition and enhancing biological availability in using indicated salt as agonist of TPO receptors for enhancing platelets producing and in treatment of thrombocytopenia also.
EFFECT: improved and valuable medicinal properties of acid.
19 cl, 2 tbl, 5 ex
Title |
Year |
Author |
Number |
CRYSTALLINE FORM OF MONOETHANOLAMINE 3'-[(2Z)-2-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOLE-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID |
2021 |
- Veretennikov Evgenij Aleksandrovich
- Egorov Sergej Anatolevich
- Tsypin Vladimir Georgievich
|
RU2778508C1 |
BICYCLOSUBSTITUTED AZOPYRAZOLONE DERIVATIVES SALTS, METHOD FOR PREPARING AND USING THEM |
2010 |
- Tan Pehn Cho
- Lu Khehtszjun'
- Fehj Khunbo
- Chehn' Itsjan'
|
RU2538977C2 |
CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS |
2010 |
- Kristin Brazerton-Plejss
- Ralf N'Ju Kharris Iii
- Brehdli Eh. Lo
- Fransisko-Khav'Er Lopes-Tapija
- Pankadzh D. Rege
- Dejvid Brjus Repke
- Rassel Stiven Stabler
- Kejt Adrian Marri Uolker
|
RU2533122C2 |
2-(3,4-DIMETHYLPHENYL)-4-{[2-HYDROXY-3'-(1H-TETRAZOLE-5-YL)BIPHENYL-3- YL]HYDRAZONO}-5-METHYL-2,4-DIHYDROPYRAZOLE-3-ONE-CHOLINE |
2004 |
- Bruk Kristofer S.
- Pin Li-Tszen Ts.
|
RU2379297C2 |
1-SULFONYL-1,3-DIHYDROINDOLE-2-ONES, PHARMACEUTICAL COMPOSITIONS (VARIANTS), METHOD FOR THEIR PREPARING AND APPLYING |
2003 |
- Ivashchenko A.V.
- Khvat Aleksandr Viktorovich
- Kravchenko D.V.
- Tkachenko S.E.
- Okun' Il'Ja Matusovich
|
RU2259999C2 |
4-OXO-1-(3-SUBSTITUTED PHENYL)-1,4-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXAMIDES, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF, METHOD FOR TREATMENT AND PROPHYLAXIS AND METHOD FOR IMPROVING COGNITIVE ABILITY IN HEALTH SUBJECT |
2003 |
- Djub Daniel'
- Gallan Mishel'
- Ljakomb Patrik
- Aspiotis Rene
- Djub Lorans
- Zhirar Iv
- Makdonal'D Duajt
|
RU2312865C2 |
DERIVATIVES OF BENZODIAZEPINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2001 |
- Raffaehllo Maschiadri
- Ehndr'Ju Uill'Jam Tomas
- Jurgen Vikhmann
|
RU2278865C2 |
CATECHOL-O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN TREATING PSYCHOTIC DISORDERS |
2011 |
- Uolkenberg Skott
- Berrou Dzhejms K.
- Poslasni Majkl S.
- Kharrison Skott T.
- Trotter B. Uesli
- Malkhirn Dzhejms
- Nanda Kausik K.
- Menli Piter Dzh.
- Chzhao Chzhitszyan
- Shubert Dzheffri V.
- Kett Natan
- Zartman Emi
|
RU2586974C2 |
PHARMACEUTICAL COMPOSITION CONTAINING A BICYCLO-SUBSTITUTED AZO DERIVATIVE OF PYRAZOLONE OR A SALT THEREOF, AND A METHOD FOR PRODUCTION THEREOF |
2017 |
- Lu, Yun
- Chzhan, Sinkhua
- Chzhan, Dajmej
|
RU2733844C2 |
DERIVATIVES OF HYDRAZONE-PYRAOLE AND MEDICAL APPLICATION THEIROF |
2002 |
- Chzhan Tszajkhuj
- Dehjnard Timoti S.
- Shafeev Mikhail A.
- Van Shizen
- Chopiuk Greg B.
- Sviridov Sergej V.
|
RU2332996C2 |